Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.

Olin RL, Nichols KE, Naghashpour M, Wasik M, Shelly B, Stadtmauer EA, Vogl DT.

Am J Hematol. 2008 Sep;83(9):747-9. doi: 10.1002/ajh.21236.

2.
3.

Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.

Bielekova B, Howard T, Packer AN, Richert N, Blevins G, Ohayon J, Waldmann TA, McFarland HF, Martin R.

Arch Neurol. 2009 Apr;66(4):483-9. doi: 10.1001/archneurol.2009.50.

4.

Monitoring of T-cell subsets in patients treated with anti-CD 25 antibody.

Praditpornsilpa K, Avihingsanon Y, Kupatawintu P, Songpanich S, Pisitkul T, Kansanabuch T, Eiam-Ong S, Chusil S, O-Charoen R, Tungsanga K.

Transplant Proc. 2004 Mar;36(2 Suppl):487S-491S.

PMID:
15041394
5.

Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.

Shah NN, Harrison N, Stonecypher M, Frank D, Amorosa V, Svoboda J.

Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):e157-60. doi: 10.1016/j.clml.2014.05.001. Epub 2014 Jun 11. No abstract available.

PMID:
25027567
6.

Successful treatment with daclizumab of refractory anaplastic lymphoma.

Costa V, Oliva T, Norton L.

Pediatr Blood Cancer. 2009 Dec;53(6):1130-1. doi: 10.1002/pbc.22177.

PMID:
19598219
7.

Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.

Suzumiya J, Ohshima K, Kanda M, Kumagawa M, Nagano M, Hirata M, Nawa Y, Tamura K, Kikuchi M.

Leuk Lymphoma. 2000 May;37(5-6):593-604.

PMID:
11042520
8.

Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).

Ceesay MM, Matutes E, Taylor GP, Fields P, Cavenagh J, Simpson S, Ho A, Devereux S, Mufti GJ, Pagliuca A.

Leuk Res. 2012 Jul;36(7):857-61. doi: 10.1016/j.leukres.2011.12.004. Epub 2011 Dec 29.

PMID:
22209076
9.

Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis.

Martin R.

Clin Immunol. 2012 Jan;142(1):9-14. doi: 10.1016/j.clim.2011.10.008. Epub 2011 Nov 9. Review.

PMID:
22284868
10.

Spotlight on anti-CD25: daclizumab in MS.

Schippling DS, Martin R.

Int MS J. 2008 Sep;15(3):94-8. Review.

PMID:
18808743
11.

Treatment of hemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine, and prednisone.

Hu Y, Xu J, Wang L, Li J, Qiu H, Zhang S.

Swiss Med Wkly. 2012 Feb 3;142:w13512. doi: 10.4414/smw.2012.13512.

12.

[Hemophagocytic lymphohistiocytosis].

Imamura Y.

Rinsho Ketsueki. 2014 Feb;55(2):223-33. Review. Japanese. No abstract available.

PMID:
24598190
13.

Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.

Rodriguez V, Anderson PM, Trotz BA, Arndt CA, Allen JA, Khan SP.

Pediatr Blood Cancer. 2007 Aug;49(2):212-5. Review.

PMID:
16261610
14.

Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.

Chen J, Zhang M, Ju W, Waldmann TA.

Blood. 2009 Feb 5;113(6):1287-93. doi: 10.1182/blood-2008-04-149658. Epub 2008 Oct 23.

15.

A case of anaplastic large cell lymphoma-induced hemophagocytic lymphohistiocytosis in an adolescent female.

Krenova Z, Sterba J, Blatny J, Kren L, Slany J.

Pediatr Blood Cancer. 2007 Dec;49(7):1056. No abstract available.

PMID:
17405157
16.

Hemophagocytic lymphohistiocytosis (HLH) in a 25-year-old presenting with multisystem organ failure.

Lane S, Andrist C, Nagarajan A.

W V Med J. 2013 Nov-Dec;109(6):22-3.

PMID:
24371860
17.

Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.

Zhang Y, McClellan M, Efros L, Shi D, Bielekova B, Tang MT, Vexler V, Sheridan JP.

Mult Scler. 2014 Feb;20(2):156-64. doi: 10.1177/1352458513494488. Epub 2013 Jul 11.

18.

Successful autologous peripheral blood stem cell transplantation for a patient with primary adrenal lymphoma with hemophagocytic syndrome.

Uehara T, Yokota A, Onoda M, Yamamoto K, Terano T.

Clin Lymphoma Myeloma. 2008 Jun;8(3):184-7. doi: 10.3816/CLM.2008.n.024.

PMID:
18650184
19.

Hemophagocytic syndrome occurred in a patient with subcutaneous panniculitis-like T-cell lymphoma without overt skin lesion: successful treatment with steroid pulse therapy.

Miura T, Kawakami Y, Sato M, Ohtsuka M, Yamamoto T.

J Dermatol. 2011 Nov;38(11):1113-5. doi: 10.1111/j.1346-8138.2010.01178.x. Epub 2011 May 4. No abstract available.

PMID:
21545491
20.

Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis.

Faguer S, Vergez F, Peres M, Ferrandiz I, Casemayou A, Belliere J, Cointault O, Lavayssiere L, Nogier MB, Prevot G, Huart A, Recher C, Rostaing L.

Hematol Oncol. 2016 Mar;34(1):55-7. doi: 10.1002/hon.2174. Epub 2014 Oct 13. No abstract available.

PMID:
25312407

Supplemental Content

Support Center